Impact of Chronic Kidney Disease - Mineral and Bone Disorder(CKD-MBD) on anemia

Impact of CKD-MBD on anemia - Impact of CKD-MBD on anemia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000058732

Enrollment

8800

Registered

2025-08-08

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese Dialysis Patients with CKD-MBD

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patients attending a dialysis facility as outpatients who agree to participate in the study

Exclusion criteria

Exclusion criteria: Patients on peritoneal dialysis

Design outcomes

Primary

Measure	Time frame
As anemia-related outcomes, we will assess erythropoietin resistance index, platelet count, hemoglobin levels, the dose of erythropoiesis-stimulating agents, C-reactive protein levels, iron sequestration index, and the use of iron preparations (oral and intravenous).	—

Countries

Japan

Contacts

Public ContactKoji Kabaya

Patient Driven Academic League Administrative Division

admin@pedal.or.jp075-777-1261

Outcome results